ITRM

Iterum Therapeutics plc

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

12

Buys

5

Sells

5

Largest Trade

N/A

Insiders

5

Institutional Funds

17

Inst. Value

$100K–$500K

Activist Filings

4

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Dunne Michael W.DirectorBUY$1K–$15K6K$0.37Nov 20, 2025
Dunne Michael W.DirectorBUY$15K–$50K25K$1.40Dec 27, 2023
Dunne Michael W.DirectorBUY$15K–$50K20K$2.03Nov 27, 2023
Fishman Corey N.CEOBUY$15K–$50K10K$1.59Nov 20, 2023
Puttagunta SailajaChief Medical Offi…GRANTN/A8KDec 5, 2022
Puttagunta SailajaChief Medical Offi…SELL$1K–$15K3K$1.32Dec 5, 2022
Ahrens Brenton KarlDirectorSELL$50K–$100K37K$1.82Sep 20, 2022
Ahrens Brenton KarlDirectorSELL$50K–$100K45K$2.09Sep 15, 2022
Ahrens Brenton KarlDirectorSELL$50K–$100K33K$2.31Sep 13, 2022
Dunne Michael W.DirectorBUY$15K–$50K10K$2.22Sep 9, 2022
Matthews Judith M.CFOGRANTN/A100KMar 15, 2022
Matthews Judith M.CFOSELL$15K–$50K47K$0.38Mar 15, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 17 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Armistice Capital, LLC

SC 13G/A · Feb 14, 2025

5.0%

1.4M shares

Point72 Asset Management, L.P.

SC 13G/A · Nov 15, 2024

0.0%

0 shares

Armistice Capital, LLC

SC 13G · Nov 14, 2024

6.0%

1.3M shares

0.0%

0 shares

View on Google Finance →